Bevasiranib
Bevasiranib is a small interfering RNA (siRNA) therapeutic agent designed to inhibit vascular endothelial growth factor (VEGF) expression. It is applied in research models of choroidal neovascularization (CNV) and wet age-related macular degeneration (wet AMD), supporting both in vitro mechanistic studies and in vivo preclinical investigations.
Product Specifications
CAS Number
959961-96-7
Field of Research
Cardiovascular Research, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog